Durable remission of renal cell carcinoma in conjuncture with graft versus host disease following allogeneic stem cell transplantation and donor lymphocyte infusion: rule or exception?

HIGHLIGHTS

• who: Lymphocyte Infusion Rule or and colleagues from the Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands, Department of Clinical Oncology, Leiden University Medical Center, Leiden have published the research: Durable Remission of Renal Cell Carcinoma in Conjuncture with Graft versus Host Disease following Allogeneic Stem Cell Transplantation and Donor Lymphocyte Infusion: Rule or Exception?, in the Journal: PLOS ONE | www.plosone.org of January/15,/2014
• what: The authors describe a patient with clear cell RCC who showed tumor regression and prolonged survival after alloSCT followed by DLI.
• how: The . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.